How do you successfully take a UK Medtech product into France?
On 10 July 2026, Strategic Healthcare Advisors (SHA) partnered with UK Business Centre Lille (UKBC) and the UK Department for Business and Trade (DBT) to host a live webinar designed for British founders, commercial leaders, and innovators exploring the French healthcare market.
During the session, SHA’s experts — Dr Caroline Chauché and Eric Del Cotto — joined colleagues from UK Business Centre Lille, BioClavis, Covartim, Nord France Invest, and Forvis Mazars France to share practical insights on the regulatory, commercial, legal, and financing considerations that shape a successful market entry strategy.
The discussion covered:
• Navigating CE MDR and IVDR regulatory pathways
• Understanding HAS reimbursement and GHT procurement routes
• Building effective distributor partnerships and clinical KOL networks
• Developing a practical route to commercial success in France
The webinar attracted medtech companies from the UK, India, and beyond, alongside trade representatives from the UK Department for Business and Trade, Scottish Development International, and the Canadian Embassy in France—highlighting the growing international interest in the French healthcare market.
If you’re considering expansion into France or the wider European market, watch the webinar to learn how SHA helps international health-tech companies identify the right regulatory, commercial, and financing pathway for success.
